July 29, 2014

blue-compass
  • Kim Dueholm resigned as a Board Member from Akebia Therapeutics, Inc.
  • Maxine Gowen joined Akebia Therapeutics, Inc. as a Board Member.
  • Robert E. Gruwell was appointed to Executive Vice President, Finance and Principal Financial Officer at Federal Home Loan Bank of Indianapolis.
  • Michael D. Clayman joined Akebia Therapeutics, Inc. as a Board Member.
  • Timothy Salvemini became Chief Administrative Officer at Rouse Properties, Inc.

July 28, 2014

blue-compass
  • Michael Zhang resigned as a Board Member from China Shengda Packaging Group Inc.
  • Bruce A. Los resigned as Senior Vice President from Gentex Corp.
  • Edward Colbey Davies resigned as Senior Vice President and President, Federal Systems from Unisys Corporation.
  • Shlomo Yanai was appointed to Chairman of the Board at Protalix BioTherapeutics, Inc.
  • Zeev Bronfeld was appointed to Board Member at Protalix BioTherapeutics, Inc.

Are CEOs worth the Millions They’re Paid? – USA Today

“Controversy over CEO pay is never far from the headlines, and Americans are well aware that CEOs are paid several hundred times what the average front-line worker gets. However, that metric only illustrates the level of income disparity in our economy. It’s not a useful tool for figuring how much CEOs should be paid — a key question for investors.”
Read Full Article